CDC Data Contradicts White House Overdose Claims
Researchers say drug death declines began under Biden, challenging the administration's assertion that gains stem from recent border policies.
By Tomas Gonzalez ·

The White House claims a historic drop in U.S. drug overdose deaths is a direct result of President Trump’s recent border security measures. New CDC data and expert analysis suggest the timeline is inaccurate and the causes are more complex than the administration admits.
Earlier this week, officials announced that fatal drug overdoses have fallen to their lowest level in roughly a decade. The Office of National Drug Control Policy stated this shift saves nearly 50,000 lives annually. Director Sara Carter attributed the success to heightened border enforcement and the dismantling of narco-terrorist organizations.
Carter’s statement cited a 41.5% decrease in total drug overdose deaths compared to the peak under the previous administration. She argued that the Biden era oversaw the highest drug overdose numbers in history before bringing them down.
Leading drug policy researchers dispute that characterization. Vanda Felbab-Brown of the Brookings Institution noted that a steady decline in overdose deaths began in the spring of 2023. This timeline extends well beyond the 18 months highlighted in the White House announcement.
CDC records show reductions in drug deaths continued for at least 39 consecutive months. By the time Biden left office, fatal overdoses had already dropped by roughly one-third. Nabarun Dasgupta, a researcher at the University of North Carolina at Chapel Hill, identified the trend’s start as early as 2021 in some regions.
Experts credit the Biden administration with specific policy responses. These included wider healthcare access, increased availability of naloxone, and a deal with China to disrupt industrial chemicals used for fentanyl production. The administration also intensified interdiction efforts against Mexican cartels.
Carter responded to the earlier data by stating that progress on a graph is not necessarily real progress. She maintained that the Trump administration is now positioned to build on these reductions by continuing to attack drug gangs. However, Felbab-Brown argued that no major narco-terrorist organization has been dismantled and that all continue to operate and smuggle drugs.
Concerns remain about the durability of these gains. Dasgupta warned that deep cuts to Medicaid, estimated to affect up to 10 million Americans, could undermine progress. Medicaid is the largest funder of addiction services in the United States. Cutting eligibility risks leaving patients without effective treatment.






